Weick Jk
- Hematology top 2%
- Acute Myeloid Leukemia Research 2
-
- Acute Lymphoblastic Leukemia research 3
- Genetics top 10%
-
- Neutropenia and Cancer Infections 3
- Cancer Treatment and Pharmacology 2
- Lung Cancer Research Studies 2
-
- Lung Cancer Treatments and Mutations 3
-
- Cancer therapeutics and mechanisms 1
-
- Radiopharmaceutical Chemistry and Applications 1
- Co-authors
- KJ KopeckyMichael R. GreverFR AppelbaumJ. BickersS SimonBalcerzak SpSteve DahlbergDavid Head
- Journals
- Blood (3 papers)PubMed (7 papers)
- Partner nations
- United States
In The Last Decade
Weick Jk
10 papers receiving 569 citations
Peers
Comparison fields: 5 of 51
- Hematology 440
- Public Health, Environmental and Occupational Health 309
- Genetics 89
- Oncology 174
- Pediatrics, Perinatology and Child Health 69
Countries citing papers authored by Weick Jk
This map shows the geographic impact of Weick Jk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weick Jk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weick Jk more than expected).
Fields of papers citing papers by Weick Jk
This network shows the impact of papers produced by Weick Jk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weick Jk. The network helps show where Weick Jk may publish in the future.
Co-authorship network
The 22 scholars most cited alongside Weick Jk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 296 | |
| 2 | 1989 | 113 | |
| 3 | 1989 | 95 | |
| 4 | Phase II evaluation of teniposide and ifosfamide in refractory adult acute lymphocytic leukemia: a Southwest Oncology Group Study. | 1987 | 5 |
| 5 | Gallium nitrate in malignant lymphoma: a Southwest Oncology Group study. | 1983 | 24 |
| 6 | Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study. | 1982 | 12 |
| 7 | Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study. | 1981 | 1 |
| 8 | Simultaneous treatment with cisplatin and radiation therapy for advanced solid tumors: a pilot study. | 1981 | 28 |
| 9 | Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas. | 1980 | 26 |
| 10 | Chemotherapy of metastatic gastrointestinal neoplasms with 5-fluorouracil and streptozotocin. | 1977 | 4 |
About Weick Jk
Weick Jk is a scholar working on Oncology, Hematology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Genetics, having authored 10 papers that have together received 604 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Acute Myeloid Leukemia Research (2 papers), Cancer Treatment and Pharmacology (2 papers), Lung Cancer Research Studies (2 papers), Cancer therapeutics and mechanisms (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Hematology (440 citations), Public Health, Environmental and Occupational Health (309 citations), Genetics (89 citations), Oncology (174 citations) and Pediatrics, Perinatology and Child Health (69 citations). Weick Jk has collaborated with scholars based in United States. Frequent co-authors include KJ Kopecky, Michael R. Grever, FR Appelbaum, J. Bickers, S Simon, Balcerzak Sp, Steve Dahlberg, David Head, Earl N. Metz and S E Rivkin. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.